<DOC>
	<DOCNO>NCT00956553</DOCNO>
	<brief_summary>This phase IV study evaluate body 's immune response participant Cervarix Gardasil vaccine Human Papilloma Virus ( HPV ) type associate increased risk cervical cancer .</brief_summary>
	<brief_title>Reactogenicity Study Cervarix Gardasil UK Adolescent Girls</brief_title>
	<detailed_description>This study look possible cross reactivity different HPV serotypes peripheral antibody mucosally-secreted antibody .</detailed_description>
	<criteria>Aged 13 15 year time first immunisation Female No contraindication vaccination specify `` Green Book '' Immunisation Against Infectious Disease , HMSO . Written inform consent obtain parent guardian subject Pregnant become pregnant course trial ( contraindication vaccination take contraceptive pill ) . Breastfeeding mother Allergic vaccine component</criteria>
	<gender>Female</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>HPV</keyword>
	<keyword>Human Papilloma Virus</keyword>
	<keyword>Cervical cancer vaccine</keyword>
</DOC>